ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Hammer’s “March Of dollars” Starts Collecting Money; Four Year Campaign Kicks Off Oct 12

September 2, 1988

Columbia To Host U.S.- China Conference

February 15, 1980

NCAB Says President’s Budget Would “Seriously Damage” Cancer Program

February 12, 1999

Senate Confirms McClellan For FDA

October 25, 2002

In Brief: Moloney, Manaher, 11 Other NCI Staff Members Retire; Terry Takes Leave From Immunology Jobs

March 7, 1980

Is the Concept of National Chain Of Outpatient Centers Still Viable?

May 2, 1997